Reply to Nishimura, “Questions regarding mortality and infection source in deep-seated infections”
Antimicrobial Agents and Chemotherapy · 01.04.2026 · 70 (4)
DOI: 10.1128/aac.01716-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 01.04.2026. Verfasst von Nicole Slain und 1 weiteren Autor:innen. Beteiligte Einrichtung: University of Kentucky HealthCare, Lexington, Kentucky, USA. Die Arbeit nennt 2 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
T hough previous studies have suggested cefepime as a suitable option for infec tions caused by AmpC-producing Enterobacterales (AmpC-E), this study focuses on patients with deep-seated infections, where challenges, such as the inoculum effect, and pharmacokinetic considerations are more pronounced.(1) The question regarding 30-day mortality rates in comparison to 60-or 90-day mortality rates in the cefepime group is a noted observation.(2) As mentioned in the discussion, the 30-, 60, and 90-day mortality rates were similar between patients in the cefepime and carbapenem groups. Although the 30-day mortality rate was numerically higher in the cefepime group, this differ ence was not statistically significant. It is also important to clarify that these mortality endpoints represent separate, non-cumulative time windows, so deaths occurring within 30 days are not included again in the 60-or 90-day analyses. Additionally, the 30-day clinical failure endpoint incorporates both mortality and infection recurrence, whereas recurrence was not evaluated at 60 or 90 days. This distinction in endpoint definitions explains why differences were observed in 30-day clinical failure, while later mortality measures remained similar. Deep
Autor:innen und Institutionen
- University of Kentucky HealthCare, Lexington, Kentucky, USA.
- University of Kentucky College of Pharmacy, Lexington, Kentucky, USA.
ORCID-Profile: Ashlan J Kunz Coyne
Zitieren
APA
Slain, N., & Kunz Coyne, A. J. (2026). Reply to Nishimura, “Questions regarding mortality and infection source in deep-seated infections”. Antimicrobial Agents and Chemotherapy, 70(4). https://doi.org/10.1128/aac.01716-25
Vancouver
Slain N, Kunz Coyne AJ. Reply to Nishimura, “Questions regarding mortality and infection source in deep-seated infections”. Antimicrobial Agents and Chemotherapy. 2026;70(4). doi:10.1128/aac.01716-25
BibTeX
@article{Slain2026,
author = {Slain, Nicole and Kunz Coyne, Ashlan J},
title = {Reply to Nishimura, “Questions regarding mortality and infection source in deep-seated infections”},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2026},
volume = {70},
number = {4},
doi = {10.1128/aac.01716-25}
}
EUVIMED